TP ICAP Group PLC (TCAP.L) Bundle
When investors look beneath the surface of TP ICAP Group PLC's latest numbers, the story is one of steady top-line momentum and tighter balance-sheet control: full-year revenue reached £2,253m in 2024 (up from £2,191m in 2023) while the first half of 2025 delivered a 9% rise to £1.2bn, driven by a 10% surge in Global Broking and a record 14% lift at Liquidnet even as E&C dipped 2%; profitability improved too, with adjusted EBIT up 10% to £184m (15.0% margin) in H1 2025 and full-year operating profit at £236m, supported by EPS rising to 22.1p in 2024 from 9.1p a year earlier; capital strategy has been active-gross debt reduced by c.£80m in 2024 to a 1.6x leverage ratio, a £250m bond issued in June 2025 (nearly four times oversubscribed), £150m of buybacks over 24 months plus an additional £30m in August 2025, and cash conversion strengthening to 144% (unrestricted cash up c.£70m)-all factors that feed valuation assumptions (analysts forecast EPS growth ~9.4% p.a. and a consensus price target of £3.11) and set the scene for the detailed breakdown ahead; read on to unpack the numbers, risks and upside opportunities driving investor decisions.
TP ICAP Group PLC (TCAP.L) Revenue Analysis
In 2024 TP ICAP Group PLC reported total revenue of £2,253 million (up 3% from £2,191 million in 2023). The first half of 2025 delivered a stronger trajectory with revenue of £1,200 million, a 9% increase versus H1 2024 (H1 2024: £1,101 million).- FY 2024 revenue: £2,253m (▲3% vs FY 2023: £2,191m)
- H1 2025 revenue: £1,200m (▲9% vs H1 2024: £1,101m)
- Global Broking: 58% of Group revenue; H1 2025 growth +10%
- Liquidnet: record H1 2025 growth +14%
- Energy & Commodities (E&C): H1 2025 decline -2%
- Parameta Solutions: H1 2025 growth +3% (subscription-backed)
| Metric / Period | FY 2023 | FY 2024 | H1 2024 | H1 2025 |
|---|---|---|---|---|
| Total revenue (£m) | 2,191 | 2,253 | 1,101 | 1,200 |
| Global Broking - contribution (% of Group) | - | - | ~58% | ~58% (≈£696m) |
| Global Broking - H1 change | - | - | - | +10% (vs H1 2024) |
| Liquidnet - H1 revenue | - | - | ≈£63m | ≈£72m (▲14%) |
| Energy & Commodities - H1 revenue | - | - | ≈£98m | ≈£96m (-2%) |
| Parameta Solutions - H1 revenue | - | - | ≈£47m | ≈£48m (▲3%) |
- Drivers behind H1 2025 outperformance: favourable market conditions boosting client activity, strong Global Broking volumes, and record growth at Liquidnet.
- Headwinds: competitive hiring market weighing on E&C margins and near-term revenue for that segment.
TP ICAP Group PLC (TCAP.L) - Profitability Metrics
TP ICAP Group PLC's recent results show strengthening profitability across key measures, driven by higher adjusted EBIT, improved margins and a meaningful rise in EPS.
- Adjusted EBIT for H1 2025: £184 million (up 10% year-on-year)
- Adjusted EBIT margin H1 2025: 15.0% (from 14.8% in H1 2024)
- Operating profit (EBIT) 2024: £236 million (versus £128 million in 2023)
- Basic EPS 2024: 22.1p (versus 9.1p in 2023)
- Operating profit margin 2024: 10.5% (from 5.8% in 2023)
- Interim dividend H1 2025: increased 10% to 5.2p per share
| Metric | 2023 | 2024 | H1 2024 | H1 2025 |
|---|---|---|---|---|
| Operating profit (EBIT) | £128m | £236m | - | - |
| Adjusted EBIT | - | - | £167.3m (implied) | £184m |
| Adjusted EBIT margin | - | - | 14.8% | 15.0% |
| Operating profit margin | 5.8% | 10.5% | - | - |
| Basic EPS | 9.1p | 22.1p | - | - |
| Interim dividend | - | - | 4.727p (implied prior) | 5.2p |
Key drivers include higher trading volumes and margin improvement across client-facing businesses, supporting both absolute profit growth and enhanced profitability ratios. For corporate context and strategic alignment, see Mission Statement, Vision, & Core Values (2026) of TP ICAP Group PLC.
TP ICAP Group PLC (TCAP.L) - Debt vs. Equity Structure
TP ICAP has materially reshaped its capital structure since 2023, prioritising deleveraging, active liability management and shareholder returns while preserving flexibility for operational investment. The Group's actions include gross debt reduction, bond refinancing, substantial tender activity, sustained share buybacks and a dividend policy targeting roughly half of adjusted post-tax earnings.- Gross debt reduced by c. £80m in 2024, lowering reported leverage to 1.6x (from 1.9x in 2023).
- Issued a new £250m bond in June 2025 (nearly 4x oversubscribed) and tendered ~92% of its 2026 bond.
- Returned £120m to shareholders via buybacks over the past 18 months; an additional £30m buyback announced in Aug 2025 brings the 24‑month total to £150m.
- Launched a three‑year operational efficiency programme in H2 2024 aimed at releasing ≥£50m of surplus cash through legal entity consolidations.
- Dividend policy targets ~50% payout of adjusted post‑tax earnings; total dividend increased by 13% for 2025.
| Metric | 2023 | 2024 | June 2025 / H1‑H2 2025 |
|---|---|---|---|
| Reported leverage (x) | 1.9 | 1.6 | 1.6 (post bond issue/tender impact) |
| Gross debt change (year-on-year) | - | -£80m | Net neutral to slightly lower (refinancing via £250m bond) |
| Bond issuance | - | - | £250m new bond (Jun 2025), ~4x oversubscribed |
| Bond tender activity | - | - | ~92% of 2026 bond tendered |
| Share buybacks (cumulative) | - | £120m (last 18 months including 2024) | Additional £30m announced Aug 2025; £150m total over 24 months |
| Operational efficiency target | - | Launched H2 2024 | At least £50m surplus cash to be released over 3 years |
| Dividend policy | Target ~50% of adjusted post‑tax earnings | Maintained | Total dividend +13% for 2025 |
- Implications for bondholders: refinancing with the £250m issuance and high tender participation materially shortens near‑term maturity concentration and demonstrates market access (oversubscription ~4x).
- Implications for equity holders: a sustained buyback programme (£150m over 24 months) plus a 13% dividend increase signals commitment to returning capital and supports EPS accretion.
- Balance‑sheet flexibility: targeted £50m of surplus cash from entity consolidation and the improved leverage ratio provide headroom for strategic optionality.
TP ICAP Group PLC (TCAP.L) - Liquidity and Solvency
TP ICAP's liquidity and solvency profile strengthened through 2024-2025, driven by improved cash conversion, rising unrestricted cash balances, targeted share buybacks and a well-received bond issuance that demonstrated market confidence.- Cash conversion ratio: 144% in 2024, up from 124% in 2023 - indicating stronger conversion of reported profits into cash flow.
- Unrestricted cash increased by approximately £70.0m over the past 12 months, bolstering near-term liquidity.
- Leverage (net debt / adjusted EBITDA) improved to 1.6x in 2024 from 1.9x in 2023 - reflecting enhanced solvency and balance sheet deleveraging.
| Metric | 2023 | 2024 | Notable 2025 Events |
|---|---|---|---|
| Cash conversion ratio | 124% | 144% | - |
| Unrestricted cash (change) | Baseline | +£70m (12 months) | £30m share buyback (Aug 2025) |
| Leverage (x) | 1.9x | 1.6x | Improved headroom for capital returns and investment |
| Share buybacks (rolling 24 months) | - | £150m (total over 24 months) | Additional £30m repurchase announced Aug 2025 |
| Debt market action | - | - | £250m bond issuance (Jun 2025), nearly 4x oversubscribed |
- The £250m bond issuance in June 2025, nearly four times oversubscribed, signalled investor confidence and favourable funding conditions.
- Capital returns: £150m of buybacks executed over the prior 24 months, plus the £30m programme in August 2025, indicate active shareholder returns enabled by cash generation and lower leverage.
- Combined actions - stronger cash conversion, higher unrestricted cash, buybacks and the oversubscribed bond - point to disciplined capital management and improved liquidity resilience.
TP ICAP Group PLC (TCAP.L) - Valuation Analysis
Analysts forecast TP ICAP's earnings to grow by 9.4% per annum, with EPS expected to reach £0.23 in 2025. The consensus price target sits at £3.11, reflecting investor confidence in the company's valuation. Recent capital actions and cash movements further support a favorable valuation outlook.
- Analyst EPS growth forecast: 9.4% CAGR to 2025 (EPS forecast £0.23 in 2025).
- Consensus price target: £3.11 per share.
- Share buybacks: £30m announced Aug 2025; £150m repurchased over last 24 months; £120m returned via buybacks over past 18 months.
- Debt and liquidity: £250m bond issuance in June 2025; unrestricted cash increased by £70m over the past 12 months.
| Metric | Value | Date / Period |
|---|---|---|
| Analyst EPS growth (CAGR) | 9.4% | To 2025 |
| Forecast EPS | £0.23 | 2025 |
| Consensus price target | £3.11 | Current consensus |
| Share buyback (announced) | £30m | Aug 2025 |
| Share buybacks (24 months) | £150m | Last 24 months |
| Shareholder returns via buybacks (18 months) | £120m | Past 18 months |
| Bond issuance | £250m | June 2025 |
| Increase in unrestricted cash | £70m | Past 12 months |
- Capital management signals: large buybacks and a sizeable bond issuance point to management confidence in valuation-accretive deployment of capital.
- Liquidity and leverage: £70m rise in unrestricted cash combined with the £250m bond indicates active balance sheet optimization rather than distress financing.
- Investor signal: consensus £3.11 target plus repeated buybacks (totaling £120-£150m across recent periods) demonstrates a clear focus on returning value to shareholders.
Further context on strategic aims and governance is available here: Mission Statement, Vision, & Core Values (2026) of TP ICAP Group PLC.
TP ICAP Group PLC (TCAP.L) - Risk Factors
The following risk factors combine operational, market and capital structure elements that investors should weigh when assessing TP ICAP Group PLC (TCAP.L).- Energy & Commodities (E&C) division performance: revenue declined 2% in H1 2025, reflecting margin pressure from a competitive hiring market and potential market-share sensitivity to staffing dynamics.
- Recruitment and personnel costs: a tight hiring market can push up compensation, reducing segment margins and increasing volatility in quarterly results.
- Market concentration risk: adverse moves in key commodities or interest-rate sensitive products can disproportionately affect E&C revenues.
- Execution risk on capital management: large buybacks and debt issuance require continued free cash flow to avoid balance-sheet strain if trading conditions worsen.
- Leverage and refinancing risk: the June 2025 £250m bond issuance increases fixed obligations; adverse rate moves or credit-spread widening would raise refinancing costs.
- Liquidity risk: while unrestricted cash is up, rapid market dislocations could increase working capital needs for intermediation businesses.
- Regulatory and compliance risk: as a global interdealer broker, changes in market structure or regulation could raise costs or limit revenue opportunities.
- Share-price sensitivity: material capital returns (buybacks) can create short-term EPS uplift but also heighten share-price sensitivity to any earnings miss.
| Metric | Amount | Period / Note |
|---|---|---|
| E&C revenue change | -2% | H1 2025 |
| Share buyback (Aug 2025) | £30.0m | Program announced Aug 2025 |
| Bond issuance | £250.0m | Issued Jun 2025 |
| Total share buybacks (last 24 months) | £150.0m | Aggregate capital return |
| Cash - increase in unrestricted cash | £70.0m | Past 12 months |
| Share buybacks returned to shareholders | £120.0m | Past 18 months |
- Capital-allocation signal: the £30m August 2025 buyback and the June 2025 £250m bond issuance both indicate management's positive view on valuation and willingness to use leverage to enhance shareholder returns.
- Balance of returns versus resilience: while £150m returned via buybacks in 24 months and £120m in 18 months demonstrate commitment to shareholder value, they reduce available capital cushions if revenue shocks deepen.
- Cash position: a £70m increase in unrestricted cash over 12 months supports short-term liquidity, yet investors should monitor working-capital needs tied to broking activity cycles.
TP ICAP Group PLC (TCAP.L) - Growth Opportunities
TP ICAP's recent capital actions and balance-sheet improvements point to multiple avenues for valuation upside, liquidity flexibility and shareholder returns. Strategic use of buybacks alongside bond financing suggests management confidence in long-term cash generation and market positioning within global interdealer broking and data services.- August 2025: £30 million share buyback program launched to support share price and reduce outstanding equity.
- June 2025: £250 million bond issuance to optimize the capital structure and provide low-cost, longer-dated funding.
- Last 24 months: £150 million cumulative share buybacks demonstrating disciplined capital allocation toward valuation enhancement.
- Past 18 months: £120 million returned to shareholders via share buybacks, reflecting a shareholder-first return policy.
- Past 12 months: Unrestricted cash up by £70 million, strengthening liquidity and giving optionality for M&A, further buybacks or deleveraging.
| Event | Timing | Amount | Primary Impact |
|---|---|---|---|
| Share buyback program | August 2025 | £30 million | Share count reduction, price support |
| Bond issuance | June 2025 | £250 million | Strengthened balance sheet, lower marginal cost of debt |
| Aggregate buybacks (24 months) | Rolling 24 months | £150 million | Capital returned, valuation enhancement |
| Shareholder returns (18 months) | Past 18 months | £120 million | Direct shareholder value delivery |
| Unrestricted cash change | Past 12 months | +£70 million | Improved liquidity and optionality |
TP ICAP Group PLC (TCAP.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.